Abstract
Context
Systemic metastasis to a primary tumor of the central nervous system is uncommon. Breast carcinomas metastasizing to a possibly preexisting meningioma in the spine are reported very rarely.
Study design
Case report.
Findings
A 69-year-old female was referred to us with progressive gait disturbance. She had undergone a total mastectomy for carcinoma of the right breast 11 years previously. A magnetic resonance imaging of the thoracic spine showed an intra- and extradural spinal cord tumor. The patient underwent resection of the tumor via laminectomy from T2 to T4. After the operation, the patient's neurological status improved significantly, and she was able to walk without assistance. Histological examination showed the tumor to be a fibrous-type meningioma within a metastatic breast cancer tumor. The patient underwent 40 Gy radiation treatment for local control of the tumor. However, the tumor recurred locally 7 months after the surgery. The patient died of carcinomatous pleurisy 13 months after the surgery.
Conclusion
This case illustrates that a primary meningioma in the thoracic spine can be a recipient of breast cancer metastasis, which may alter the treatment strategy.
Keywords: Breast carcinoma, Metastasis, Meningioma, Thoracic spine
Context
Advanced cancer metastases to a central nervous system tumor are rare. When it happens, the metastatic tumor is most often a meningioma.1–11 Several hypotheses explaining the mechanism of distant metastases to a pre-existing central nervous system tumor have been proposed, and include the rich vascularity of the pre-existing tumor or hormonal or immunologic factors, but the underlying mechanism remains unclear. Most papers published on this subject have been case reports or a small case series,2–4,7–11 and the clinical features and distinctive radiological characteristics of this condition have not been described in detail. There are few case reports of cancer metastasizing to an intracranial meningioma; however, only two cases of metastasis to a spinal meningioma appear in the literature.2,9 Here, we present the very rare case of breast cancer metastasis to a possibly preexisting thoracic meningioma.
Case presentation
A 69-year-old female was referred to our department with a 1-month history of progressive gait disturbance and back pain. The patient had undergone total mastectomy for carcinoma of the right breast (T2N0M0: stage IIA) 11 years previously. Histological examination had revealed the breast cancer to be invasive ductal carcinoma. Estrogen and progesterone receptors were negative. The patient was treated with four cycles of adjuvant chemotherapy.
Seven years after the mastectomy, a chest radiograph revealed a right lung metastasis, and the patient underwent apical segmentectomy to remove the metastatic carcinoma. The lung metastasis had transformed into a metaplastic carcinoma, consisting of malignant bone and cartilage in addition to ordinary ductal carcinoma. Four years later, the patient began to experience numbness starting above the nipples and radiating down both legs to the top of the feet. She had no bowel incontinence. Her upper extremities had normal strength; however, the muscles of her lower extremities had weakness, graded at MMT 3. She had difficulty standing or walking without a support. Hyperactive deep tendon reflexes and Babinski's sign were present on both sides.
Upon referral to our department, contrast computed tomographic scan of the thoracic spine showed a space-occupying lesion within the spinal canal (Fig. 1). Magnetic resonance imaging (MRI) of the thoracic spine showed a diffusely enhanced extramedullary, intradural, and extradural T1 iso-intense and T2 hypo-hyperintense mass on the right side at the T2–3 level (Fig. 2). The patient underwent tumor resection following laminectomy from T2 to T4. Intraoperatively, the tumor was present in the extradural space along the T3 nerve root. An intradural portion of the tumor was found after the dura was opened longitudinally under a surgical microscope. The tumor was white, smooth, and similar to cartilaginous tissue in appearance. It was resected piecemeal, using a Cavitron Ultrasonic Surgical Aspirator (Valleylab, Boulder, CO, USA). The nerve root attached to the tumor was coagulated and resected. Gross total resection of the tumor was achieved, as viewed under a surgical microscope. Dura mater defects were repaired with artificial Gore-Tex dura.
Figure 1 .

Post-contrast computed myelography shows an extramedullary and intra-extradural mass at the T2–3 level (arrow).
Figure 2 .
MRI of the thoracic spine shows an enhancing T1 isointense and T2 hypointense-to-hyperintense mass with a ragged outline at the T2–3 level. (A) Sagittal T1-weighted image. (B) Sagittal T2-weighted image. (C) Sagittal enhanced image. (D) Axial image at the T2–3 level.
The pathological examination of the resected tumor showed it to consist mostly of malignant bone and cartilage, with a few carcinoma cells similar to the metaplastic carcinoma previously found in the lung. There was also a small amount of meningioma, composed of slender spindle cells, and a few psammoma bodies within the tumor (Fig. 3). The meningioma was subtyped as fibrous meningioma, and carcinoma nests were found within it. An immunohistochemical analysis showed that the carcinoma cells were positive for keratin and gross cystic disease fluid protein-15 (GCDFP-15), but the meningioma cells were negative for these proteins (Fig. 4), confirming the presence of metastatic breast cancer in the meningioma.
Figure 3 .

Histologic examination of the resected T2–3 intradural mass shows a nest of carcinoma cells in a background of fibrous meningioma.
Figure 4 .

Immunohistochemistry showed carcinoma cells positive for keratin (A) and gross cystic disease fluid protein-15 (B), and meningioma cells that were 1 negative for these proteins.
Postoperatively, the patient showed significant neurological improvement. She was treated with 40 Gy radiation for local disease control. She was walking without a cane or walker at the 3-month follow-up, but 7 months after the surgery she again complained of progressive gait disturbance, this time with severe back pain, which progressed to total paraplegia. A thoracic MRI showed that the tumor had recurred locally at the T2–3 level and was compressing the spinal cord (Fig. 5). The patient died of carcinomatous pleurisy 13 months after the surgery.
Figure 5 .

Postoperative MRI. Local tumor recurrence was found at the 7-month follow-up. (A) Sagittal image. (B) Axial image at T2–3 level.
Discussion
Fried reported “a systemic metastasis to cranial meningioma” in 1930.1 Subsequently, cases of advanced cancer metastasizing to central nervous system tumors, mostly intracranial tumors, have been reported.3–8 Recently, Aghi et al.9 reported that the majority of cancers metastasizing to central nervous system tumors originated from the breast (59.5%), lung (17.6%), and genitourinary organs (8.1%). Most of the recipient tumors reported were slow-growing meningiomas with rich vascularity; less frequently, the recipient tumor was a neurilemmoma.12
Factors contributing to metastases to meningioma include high vascularity, slow growth, hormonal influences, and cell-to-cell interactions. The hematogenous and hypervascular nature of meningioma is suspected to contribute positively to hematogenous metastases. In addition, the slow growth of meningioma may serve as a noncompetitive metabolic environment.8 Breast cancer and meningioma occur commonly in females in their fifth and sixth decades. Estrogen and progesterone receptors are often expressed, not only in breast tumors, but also in meningiomas,13 and the similar hormonal background may enhance metastasis. However, in the present case, neither the metastatic cancer nor the meningioma contained estrogen or progesterone receptors.
Including the present case, 32 cases of breast cancer metastasis to a central nerve meningioma have been published in English2–11 (Table 1); all of the patients were female. The most frequent meningioma subtype is the psammomatous (34.4%) followed by the transitional (31.3%). Recent cases were diagnosed by histological analysis of the surgical specimen; in early reports, metastasis was found at autopsy.1,5 With regard to intramedullary metastatic tumors, Kalayci14 reported that surgical resection improved neurologic deficits and prolonged mean survival periods. Other authors reported good outcomes for surgical treatment for breast cancer metastasis to meningioma, but it is not clear whether the positive outcomes reflected the very short follow-up periods.2,3,9,11 Some reports did not comment on postsurgical survival.5,7,8 Furthermore, none of the reports have mentioned a local recurrence of the cancer. Recurrence rates after surgical resection of spinal meningioma vary from 1.3 to 22%15; the recurrence rates of metastatic tumors should be even higher.16 There has been no report regarding a local recurrence of metastatic tumor in the meningioma despite aggressive surgery and adjuvant radiation therapy. The present case underwent gross total resection under a surgical microscope followed by radiation therapy, but had aggressive recurrence only 7 months after surgery. It is speculated that microscopic residual metastatic tumor in the meningioma can more easily re-grow, and may be more radio-resistant than usual metastatic spinal tumors. This should be investigated by a larger case series in future. Although recent six of the 32 cases of breast cancer metastasis to a central nerve meningioma (18.8%) underwent postsurgical radiation, no report described radiation doses. Due to the potential risk of recurrence after incomplete tumor resection, postoperative adjuvant radiotherapy is often indicated for spinal metastasis. Stereotactic body radiation therapy for spinal metastasis has been reported to be highly effective for pain relief (reported pain improvement rate; 85%) and for local control of the tumor (local control rate; 90%).17,18
Table 1 .
Summary of previously reported systemic metastatic breast cancer to meningioma
| Number | Author | Date | Sex | Age | Location | Treatment | Prognosis | Subtype of meningioma |
|---|---|---|---|---|---|---|---|---|
| 1 | Hockley | 1975 | F | 72 | Cervical spine C2 | S | Alive 3 weeks | Psammomatous |
| 2 | Nunnery | 1980 | F | 53 | Frontal | S | Alive 1Y | Meningothelial |
| 3 | Bucciero | 1992 | F | 63 | Frontal | S | ND | ND |
| 4 | Dibonito | 1993 | F | 85 | Vault | ND | ND | Psammomatous |
| 5 | F | 73 | Parietal | ND | ND | Transitional | ||
| 6 | F | 85 | Middle cranial fossa | ND | ND | Transitional | ||
| 7 | F | 82 | Unknown | ND | ND | Psammomatous | ||
| 8 | F | 85 | Unknown | ND | ND | Meningothelial | ||
| 9 | F | 74 | Vault | ND | ND | Psammomatous | ||
| 10 | F | 84 | Vault | ND | ND | Transitional | ||
| 11 | F | 56 | Vault | ND | ND | Psammomatous | ||
| 12 | F | 95 | Vault | ND | ND | Psammomatous | ||
| 13 | F | 66 | Parasellar | ND | ND | Psammomatous | ||
| 14 | F | 62 | Parietal | ND | ND | Transitional | ||
| 15 | F | 52 | Vault | ND | ND | Psammomatous | ||
| 16 | Salvati | 1996 | F | 47 | Sphenoid | S | Alive 11Y | Transitional |
| 17 | F | 54 | Frontal | S | Alive 4Y | Psammomatous | ||
| 18 | F | 53 | Sphenoid | S | Alive 5Y | Transitional | ||
| 19 | F | 48 | Sphenoid | S | Alive 3Y | Psammomatous | ||
| 20 | F | 55 | Parietal | S | Alive 1Y | Meningothelial | ||
| 21 | F | 49 | Sphenoid | S | Alive 2Y | Transitional | ||
| 22 | F | 61 | Sphenoid | S | Alive 3Y | Meningothelial | ||
| 23 | F | 58 | Frontal | S | Alive 2Y | Transitional | ||
| 24 | F | 50 | Sphenoid | S | Alive 7Y | Transitional | ||
| 25 | Elmaci | 2001 | F | 51 | Occipital | S | ND | ND |
| 26 | Watanabe | 2002 | F | 49 | Parasagittal | S + C | ND | Transitional |
| 27 | Aghi | 2005 | F | 55 | Cervical spine C3–4 | S + C + R | Alive 1M | Psammomatous |
| 28 | Calori | 2006 | F | 65 | Parietal | S + C + R | Alive 7M | Meningothelial |
| 29 | F | 53 | Parietal | S + R | ND | Meningothelial | ||
| 30 | F | 59 | Sphenoid | S + C + R | Die 15M | Fibrous | ||
| 31 | Lanotte | 2009 | F | 64 | Frontal | S + C + R | Alive 6M | ND |
| 32 | Present case | 2014 | F | 69 | Thoracic spine T2–3 | S + C + R | Die 13M | Fibrous |
F, female; S, surgery; ND, not described; S + C, surgery + chemotherapy; S + C + R, surgery + chemotherapy + radiation; S + R, surgery + radiation.
Including this case, there have been three reported cases of breast cancer metastasizing to spinal meningioma. In the previous cases,2,9 metastasis occurred in the upper cervical spine, at C2 and at C3–4. Myelopathy gradually developed in all cases. The interval from the breast cancer diagnosis to the metastasis to meningioma was 6 years2 in 1 case and 11 years in the present case. In the third case, the spinal cord metastasis was the first clinical manifestation of breast cancer.9
Tumors found on MRI typically appear as a mass ventral to the spinal cord with T1 isointensity, high T2 intensity, and strong gadolinium diethylenetriaminepentaacetic acid (DTPA) enhancement. Watanabe et al.19 reported that enhancement on MRI changed from homogeneous to inhomogeneous with slow tumor enlargement after metastasis. Although the present case also showed diffuse enhancement, a preoperative MRI-based diagnosis was not possible. Importantly, the meningioma was located partly in the extradural and partly in the intradural space. In all three cases of breast cancer metastatic to spinal meningioma, including the present one, the patients were treated surgically and obtained a degree of neurological improvement, at least temporarily. While adjuvant therapy was given in the previous two cases, the very short follow-up periods – only 3 weeks2 for one and 1 month9 for the other – did not allow the patients' neurological status to be fully evaluated.
Breast cancer survival rates have improved recently because of multi-disciplinary treatment modalities. Our case illustrates that while rare, it is possible for a metastatic breast cancer to develop in a thoracic spinal meningioma.
The patients were informed that data from the case would be submitted for publication, and gave her consent.
Disclaimer statements
Contributors EO, MN and MM have made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data. EO drafted the article or revised it critically for important intellectual content.
Conflicts of interest There is no conflict of interest on this report.
Ethics approval None.
Funding None.
Acknowledgment
For their help and useful comments during the preparation of this manuscript, we would like to thank Kiyoshi Inoue M.D., Kazuki Takeda M.D., Masaki Tezuka M.D., Shigeru Yanagimoto M.D., of the Department of Orthopaedic Surgery, Saiseikai Central Hospital, Hirobumi Maruiwa, M.D., of the Keiyu Orthopaedic Surgery clinic; and Kota Watanabe, M.D., of the Department of Advanced Treatment for Spine and Spinal Cord Disorders, Keio University School of Medicine.
References
- 1.Fried BM. Metastatic inoculation of a meningioma by cancer cells from a bronchiogenic carcinoma. Am J Pathol 1930;6(1):47–52. [PMC free article] [PubMed] [Google Scholar]
- 2.Hockley AD. Metastatic carcinoma in a spinal meningioma. J Neurol Neurosurg Psychiatry 1975;38(7):695–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nunnery E Jr., Kahn LB, Rudnick SA. Breast carcinoma metastatic to meningioma. Arch Pathol Lab Med 1980;104(7):392–3. [PubMed] [Google Scholar]
- 4.Bucciero A, del Basso M, Vizioli L, Carraturo S, Cerillo A, Tedeschi G. Metastasis of breast carcinoma to intracranial meningioma. Case report and review of the literature. J Neurosurg Sci 1992;36(3):169–72. [PubMed] [Google Scholar]
- 5.Bonito D, Giarelli L, Falconieri G, Bonifacio-Gori D, Tomasic G, Vielh P. Association of breast cancer and meningioma. Report of 12 new cases and review of the literature. Pathol Res Pract 1993;189(4):399–404. [DOI] [PubMed] [Google Scholar]
- 6.Salvati M, Cervoni L. Association of breast carcinoma and meningioma: report of nine new cases and review of the literature. Tumor 1996;82(5):491–3. [DOI] [PubMed] [Google Scholar]
- 7.Elmaci L, Ekinci G, Kurtkaya O, Sav A, Pamir MN. Tumor in tumor: metastasis of breast carcinoma to intracranial meningioma. Tumor 2001;87(6):423–7. [DOI] [PubMed] [Google Scholar]
- 8.Watanabe T, Fujisawa H, Hasegawa M, Arakawa Y, Yamashita J, Ueda F, et al. Metastasis of breast cancer to intracranial meningioma: case report. Am J Clin Oncol 2002;25(4):414–7. [DOI] [PubMed] [Google Scholar]
- 9.Aghi M, Kiehl TR, Brisman JL. Breast adenocarcinoma metastatic to epidural cervical spine meningioma: case report and review of the literature. J Neurooncol 2005;75(2):149–55. [DOI] [PubMed] [Google Scholar]
- 10.Caroli E, Salvati M, Giangaspero F, Ferrante L, Santoro A. Intrameningioma metastasis as first clinical manifestation of occult primary breast carcinoma. Neurosurg Rev 2006;29(1):49–54. [DOI] [PubMed] [Google Scholar]
- 11.Lanotte M, Benech F, Panciani PP, Cassoni P, Ducati A. Systemic cancer metastasis in a meningioma: report of two cases and review of the literature. Clin Neurol Neurosurg 2009;111(1):87–93. [DOI] [PubMed] [Google Scholar]
- 12.Chambers PW, Davis RL, Blanding JD, Buck FS. Metastases to primary intracranial meningiomas and neurilemomas. Arch Pathol Lab Med 1980;104(7):350–4. [PubMed] [Google Scholar]
- 13.Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000;65(10–11):795–800. [DOI] [PubMed] [Google Scholar]
- 14.Kalayci M, Cagavi F, Gul S, Yenidunya S, Acikgoz B. Intramedullary spinal cord metastases: diagnosis and treatment – an illustrated review. Acta neurochir 2004;146(12):1347–54. [DOI] [PubMed] [Google Scholar]
- 15.Nakamura M, Tsuji O, Fujiyoshi K, Hosogane N, Watanabe K, Tsuji T, et al. Long-term surgical outcomes of spinal meningiomas. Spine 2012;37(10):617–23. [DOI] [PubMed] [Google Scholar]
- 16.Soffietti R, Ruda R, Mutani R. Management of brain metastases. J Neurol 2002;249(10):1357–69. [DOI] [PubMed] [Google Scholar]
- 17.Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, et al. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial. Lancet Oncol 2012;13(4):395–402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Chang UK, Lee DH. Stereotactic radiosurgery for spinal neoplasms: current status and future perspective. J Neurosurg Sci 2013;57(2):87–101. [PubMed] [Google Scholar]
- 19.Watanabe M, Nomura T, Toh E, Sato M, Mochida J. Intramedullary spinal cord metastasis: a clinical and imaging study of seven patients. J Spinal Disord 2006;19(1):43–7. [DOI] [PubMed] [Google Scholar]

